Include your actual regulatory constraints, review process and timeline alongside the usual scope and goals — the details most generic web briefs omit are exactly what determines whether a pharma-specific agency can scope the project accurately.
A standard web project brief covers audience, goals and rough scope. For a pharmaceutical project, the missing pieces are usually the regulatory constraint (what markets, what claims are approved), the review process (who signs off, how long it typically takes) and any existing platform or governance framework you operate within.
Current platform and known pain points, target markets and languages, your MLR or review process, and any existing brand or governance constraints from a parent company if relevant. See project scoping for how we turn that into a real estimate.
Technical implementation details are usually better left to the agency to propose based on the actual requirement, rather than prescribed in the brief — a brief that specifies the solution rather than the problem often forecloses a better option.
Yes, even an approximate budget range is worth including, since it helps an agency propose something realistic rather than guessing at scope and then presenting a proposal that does not match your actual constraints. Ranges are more useful than exact figures if the final number is still uncertain.
Not necessarily — a full RFP document is not required for every project. See pharma website RFP checklist for what a more formal process would include if you are running a competitive tender, though a shorter brief is often sufficient for a smaller or more straightforward engagement.
A scoping engagement can help establish requirements before a full brief is written, particularly when internal stakeholders do not yet agree on scope. See project scoping for that process, which produces the clarity a brief needs to be useful rather than guessing at requirements no one has confirmed yet.
The brief benefits more from clarity about constraints, such as your existing platform, MLR review process and market list, than from deep technical specification, since a capable agency will translate those constraints into a technical approach. Overspecifying the technical solution risks locking out a better approach the agency might otherwise propose.
Tell us what you have, even incomplete, and we will tell you what else we would need to scope it properly.